385 related articles for article (PubMed ID: 18204450)
1. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation.
Henrickson SE; Mempel TR; Mazo IB; Liu B; Artyomov MN; Zheng H; Peixoto A; Flynn MP; Senman B; Junt T; Wong HC; Chakraborty AK; von Andrian UH
Nat Immunol; 2008 Mar; 9(3):282-91. PubMed ID: 18204450
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of T cell priming.
Henrickson SE; Mempel TR; Mazo IB; Liu B; Artyomov MN; Zheng H; Peixoto A; Flynn M; Senman B; Junt T; Wong HC; Chakraborty AK; von Andrian UH
Sci Signal; 2008 Mar; 1(12):pt2. PubMed ID: 18364513
[TBL] [Abstract][Full Text] [Related]
3. Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes.
Skokos D; Shakhar G; Varma R; Waite JC; Cameron TO; Lindquist RL; Schwickert T; Nussenzweig MC; Dustin ML
Nat Immunol; 2007 Aug; 8(8):835-44. PubMed ID: 17632517
[TBL] [Abstract][Full Text] [Related]
4. Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisions.
Henrickson SE; Perro M; Loughhead SM; Senman B; Stutte S; Quigley M; Alexe G; Iannacone M; Flynn MP; Omid S; Jesneck JL; Imam S; Mempel TR; Mazo IB; Haining WN; von Andrian UH
Immunity; 2013 Sep; 39(3):496-507. PubMed ID: 24054328
[TBL] [Abstract][Full Text] [Related]
5. Immunodominance analysis through interactions of CD8+ T cells and DCs in lymph nodes.
Wu YU; Xia L; Zhang M; Zhao X
Math Biosci; 2010 May; 225(1):53-8. PubMed ID: 20138186
[TBL] [Abstract][Full Text] [Related]
6. pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.
Ozga AJ; Moalli F; Abe J; Swoger J; Sharpe J; Zehn D; Kreutzfeldt M; Merkler D; Ripoll J; Stein JV
J Exp Med; 2016 Nov; 213(12):2811-2829. PubMed ID: 27799622
[TBL] [Abstract][Full Text] [Related]
7. The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge.
Carreño LJ; Bueno SM; Bull P; Nathenson SG; Kalergis AM
Immunology; 2007 Jun; 121(2):227-37. PubMed ID: 17313485
[TBL] [Abstract][Full Text] [Related]
8. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
9. Initial Viral Inoculum Determines Kinapse-and Synapse-Like T Cell Motility in Reactive Lymph Nodes.
Sivapatham S; Ficht X; Barreto de Albuquerque J; Page N; Merkler D; Stein JV
Front Immunol; 2019; 10():2086. PubMed ID: 31552034
[TBL] [Abstract][Full Text] [Related]
10. How antigen quantity and quality determine T-cell decisions in lymphoid tissue.
Zheng H; Jin B; Henrickson SE; Perelson AS; von Andrian UH; Chakraborty AK
Mol Cell Biol; 2008 Jun; 28(12):4040-51. PubMed ID: 18426917
[TBL] [Abstract][Full Text] [Related]
11. T cell activation is determined by the number of presented antigens.
Deeg J; Axmann M; Matic J; Liapis A; Depoil D; Afrose J; Curado S; Dustin ML; Spatz JP
Nano Lett; 2013; 13(11):5619-26. PubMed ID: 24117051
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
[TBL] [Abstract][Full Text] [Related]
13. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
14. The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation.
Bajénoff M; Granjeaud S; Guerder S
J Exp Med; 2003 Sep; 198(5):715-24. PubMed ID: 12953093
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
[TBL] [Abstract][Full Text] [Related]
16. Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.
Krueger PD; Kim TS; Sung SS; Braciale TJ; Hahn YS
J Immunol; 2015 Apr; 194(7):3213-22. PubMed ID: 25712214
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
Kelleher M; Beverley PC
J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.
Inaba K; Metlay JP; Crowley MT; Steinman RM
J Exp Med; 1990 Aug; 172(2):631-40. PubMed ID: 2373994
[TBL] [Abstract][Full Text] [Related]
19. CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.
Umeshappa CS; Huang H; Xie Y; Wei Y; Mulligan SJ; Deng Y; Xiang J
J Immunol; 2009 Jan; 182(1):193-206. PubMed ID: 19109150
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.
Koyama M; Hashimoto D; Aoyama K; Matsuoka K; Karube K; Niiro H; Harada M; Tanimoto M; Akashi K; Teshima T
Blood; 2009 Feb; 113(9):2088-95. PubMed ID: 19144988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
